Thus, several MEK inhibitors have been developed for melanoma treatment alone or in combination (Del Vecchio et al., 2015; Robert et al., 2015; Ascierto et al., 2016; Dummer et al., 2017). The gene discussed is MAP2K7; the disease is melanoma.